Changli Lu

1.1k total citations
40 papers, 679 citations indexed

About

Changli Lu is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Changli Lu has authored 40 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 15 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Changli Lu's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Diseases and Immunity (5 papers). Changli Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Diseases and Immunity (5 papers). Changli Lu collaborates with scholars based in China, United States and United Kingdom. Changli Lu's co-authors include Yongshun Chen, You Lü, Lei Zhang, Jianping Liu, Wenwu Ling, Tianfu Wen, Du He, Qiang Lu, Jiawu Li and Hong Bu and has published in prestigious journals such as Hepatology, Radiology and Journal of Hepatology.

In The Last Decade

Changli Lu

40 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changli Lu China 16 275 216 163 135 107 40 679
Toshimasa Nakao Japan 13 117 0.4× 103 0.5× 180 1.1× 133 1.0× 53 0.5× 49 741
Ian B. Nicoud United States 17 60 0.2× 117 0.5× 204 1.3× 178 1.3× 90 0.8× 33 628
Chuanjiang Li China 10 195 0.7× 143 0.7× 427 2.6× 145 1.1× 107 1.0× 39 947
Montse Pauta Spain 17 150 0.5× 156 0.7× 222 1.4× 198 1.5× 53 0.5× 42 814
S Baba Japan 12 105 0.4× 107 0.5× 210 1.3× 142 1.1× 53 0.5× 21 565
Qijun Zheng China 13 153 0.6× 97 0.4× 266 1.6× 87 0.6× 61 0.6× 24 710
Kenji Sakakibara Japan 17 200 0.7× 166 0.8× 257 1.6× 101 0.7× 79 0.7× 51 771
Andreea Cătană Romania 11 119 0.4× 233 1.1× 331 2.0× 212 1.6× 37 0.3× 41 673
Andrew Elvington United States 14 158 0.6× 35 0.2× 188 1.2× 112 0.8× 89 0.8× 16 758
Toru Igarashi Japan 16 156 0.6× 42 0.2× 261 1.6× 126 0.9× 161 1.5× 47 708

Countries citing papers authored by Changli Lu

Since Specialization
Citations

This map shows the geographic impact of Changli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Lu more than expected).

Fields of papers citing papers by Changli Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Lu. The network helps show where Changli Lu may publish in the future.

Co-authorship network of co-authors of Changli Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Lu. A scholar is included among the top collaborators of Changli Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Lu. Changli Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Wei, Dongbo Wu, Changhai Liu, et al.. (2022). Clinical features, natural history and outcomes of pseudolymphoma of liver: A case-series and systematic review. Asian Journal of Surgery. 46(2). 841–849. 3 indexed citations
2.
Zhou, Yongjie, Yuwei Chen, Xiaoyun Zhang, et al.. (2021). Brahma‐Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology. 74(2). 797–815. 25 indexed citations
3.
Yang, Lulu, Wenwu Ling, Du He, et al.. (2021). Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quantitative Imaging in Medicine and Surgery. 11(4). 1532–1542. 15 indexed citations
4.
Chen, Huayu, Dongbo Wu, Wei Jiang, et al.. (2021). Case Report: A Novel Homozygous Variant Identified in a Chinese Patient With Benign Recurrent Intrahepatic Cholestasis-Type 1. Frontiers in Medicine. 8. 705489–705489. 5 indexed citations
5.
Zhang, Xiaoyun, Chuan Li, Tianfu Wen, et al.. (2020). The Different Effects of Nucleotide and Nucleoside Analogues on the Prognosis of HBV-Related HCC After Curative Resection. Journal of Gastrointestinal Surgery. 25(6). 1419–1429. 4 indexed citations
6.
7.
Shen, Junyi, Jun Wen, Chuan Li, et al.. (2018). The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis. BMC Cancer. 18(1). 278–278. 31 indexed citations
8.
Shen, Junyi, Tianfu Wen, Weixia Chen, et al.. (2018). Model predicting the microvascular invasion and satellite lesions of hepatocellular carcinoma after hepatectomy. ANZ Journal of Surgery. 88(11). E761–E766. 8 indexed citations
9.
Qiu, Tingting, Wenwu Ling, Jiawu Li, et al.. (2017). Can ultrasound elastography identify mass-like focal fatty change (FFC) from liver mass?. Medicine. 96(39). e8088–e8088. 4 indexed citations
10.
Qiu, Tingting, Wenwu Ling, Qiang Lu, Changli Lu, & Yan Luo. (2016). Contrast-enhanced ultrasound in diagnosis of epithelioid renal angiomyolipoma with renal vein and inferior vena cava extension. Journal of Medical Ultrasonics. 43(3). 427–430. 4 indexed citations
11.
Lu, Qiang, Changli Lu, Jiawu Li, et al.. (2016). Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. Radiology. 280(1). 290–299. 34 indexed citations
12.
Lu, Changli, Jie Xia, Yongjie Zhou, et al.. (2015). Loss of Gsα impairs liver regeneration through a defect in the crosstalk between cAMP and growth factor signaling. Journal of Hepatology. 64(2). 342–351. 22 indexed citations
13.
Lu, Changli, et al.. (2015). Primary pure carcinoid tumors of the testis: Clinicopathological and immunophenotypical characteristics of 11 cases. Oncology Letters. 9(5). 2017–2022. 5 indexed citations
14.
Lu, Changli, Yan Qiu, Xufeng Lu, Gan‐di Li, & Hong Bu. (2015). Synchronous diffuse ganglioneuromatosis and multiple schwannomas of the colon: A case report and literature review. Experimental and Therapeutic Medicine. 9(3). 733–736. 7 indexed citations
15.
Lu, Qiang, Wenwu Ling, Changli Lu, et al.. (2015). Hepatocellular Carcinoma: Stiffness Value and Ratio to Discriminate Malignant from Benign Focal Liver Lesions. Radiology. 275(3). 880–888. 50 indexed citations
16.
Ling, Wenwu, Qiang Lu, Changli Lu, et al.. (2014). Effects of Vascularity and Differentiation of Hepatocellular Carcinoma on Tumor and Liver Stiffness: In Vivo and in Vitro Studies. Ultrasound in Medicine & Biology. 40(4). 739–746. 38 indexed citations
17.
Wang, Hongyue, Shaohua Zhu, Guohua Zhang, et al.. (2013). The autopsy study of 553 cases of sudden cardiac death in Chinese adults. Heart and Vessels. 29(4). 486–495. 34 indexed citations
18.
Zhang, Yangyang, Changli Lu, Jun Zhang, et al.. (2012). Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China. Addictive Behaviors. 38(1). 1424–1430. 42 indexed citations
19.
Lu, Changli, Yuan Tang, Qun‐pei Yang, et al.. (2011). Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of17 Chinese cases. Human Pathology. 42(12). 1965–1978. 21 indexed citations
20.
Chen, Yongshun, You Lü, Changli Lu, & Lei Zhang. (2009). Beclin-1 Expression is a Predictor of Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma and Correlated to Hypoxia-Inducible Factor (HIF)-1α Expression. Pathology & Oncology Research. 15(3). 487–493. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimasa Nakao Breakdown of academic impact, for papers by Ian B. Nicoud Breakdown of academic impact, for papers by Chuanjiang Li Breakdown of academic impact, for papers by Montse Pauta Breakdown of academic impact, for papers by S Baba Breakdown of academic impact, for papers by Qijun Zheng Breakdown of academic impact, for papers by Kenji Sakakibara Breakdown of academic impact, for papers by Andreea Cătană Breakdown of academic impact, for papers by Andrew Elvington Breakdown of academic impact, for papers by Toru Igarashi
Rankless by CCL
2026